Pressure Biosciences : Pressure BioSciences, Inc. to Present at the Rodman & Renshaw 8th Annual Healthcare Conference
11/02/2006| 09:15am US/Eastern
Recommend:
Pressure BioSciences, Inc. (NASDAQ: PBIO) today announced that it will
present at the Rodman & Renshaw 8th Annual
Healthcare Conference to be held at the New York Palace Hotel, New York,
NY on November 6-8, 2006. Mr. Richard T. Schumacher, PBI President and
CEO, will give a corporate overview at 9:55 am (EST) on Wednesday,
November 8th. Investors will be able to hear the presentation starting
on November 8th and for approximately 90 days
thereafter at http://www.wsw.com/webcast/rrshq10/pbio/.
About Pressure BioSciences, Inc.
Pressure BioSciences, Inc. (PBI) is a publicly traded, early-stage
company focused on the development of a novel, enabling technology
called Pressure Cycling Technology (PCT). PCT uses cycles of hydrostatic
pressure between ambient and ultra-high levels (up to 35,000 psi and
greater) to control bio-molecular interactions. PBI currently holds 13
US and 5 foreign patents covering multiple applications of PCT in the
life sciences field, including such areas as genomic and proteomic
sample preparation, pathogen inactivation, the control of enzymes,
immunodiagnostics, and protein purification.
Forward Looking Statements
Statements contained in this press release regarding the Company's
intentions, hopes, beliefs, expectations, or predictions of the future
are "forward-looking'' statements within the meaning of the Private
Securities Litigation Reform Act of 1995. These statements are based
upon the Company's current expectations,
forecasts, and assumptions that are subject to risks, uncertainties, and
other factors that could cause actual outcomes and results to differ
materially from those indicated by these forward-looking statements.
These risks, uncertainties, and other factors include, but are not
limited to, the risks and uncertainties discussed under the heading
"Risk Factors" in the Company's
Quarterly Report on Form 10-QSB for the quarter ended June 30, 2006, in
the Company's Annual Report on Form 10-KSB, as
amended, for the year ended December 31, 2005, and other reports filed
by the Company from time to time with the SEC. The Company undertakes no
obligation to update any of the information included in this release,
except as otherwise required by law.
Visit us at our website http://www.pressurebiosciences.com
© Business Wire 2006
Recommend :
